| Lupin Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.01 | 0.02 | 0.05 | 0.04 | 0.01 |
| Long Term Debt-Equity Ratio | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 |
| Current Ratio | 2.55 | 1.98 | 1.93 | 2.28 | 2.79 |
| Fixed Assets | 2.08 | 1.95 | 1.60 | 1.82 | 1.86 |
| Inventory | 5.48 | 4.90 | 3.63 | 4.00 | 4.26 |
| Debtors | 3.57 | 4.50 | 4.17 | 3.98 | 3.25 |
| Interest Cover Ratio | 58.24 | 50.42 | 6.35 | -1.62 | 41.12 |
| PBIDTM (%) | 32.82 | 24.31 | 10.43 | 3.36 | 19.66 |
| PBITM (%) | 29.01 | 19.37 | 5.56 | -1.01 | 15.11 |
| PBDTM (%) | 32.33 | 23.93 | 9.55 | 2.74 | 19.29 |
| CPM (%) | 27.23 | 20.80 | 8.65 | 2.50 | 15.93 |
| APATM (%) | 23.42 | 15.86 | 3.78 | -1.86 | 11.38 |
| ROCE (%) | 21.32 | 13.96 | 3.21 | -0.61 | 8.95 |
| RONW (%) | 17.70 | 11.92 | 2.33 | -1.19 | 6.98 |